| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $450K | +144.2% |
| R&D Expense | $3.0M | +19.3% |
| SG&A Expense | $2.2M | +853.5% |
| Operating Income | -$4.7M | -83.3% |
| Interest Expense | $11K | +12.9% |
| Pre-tax Income | -$4.6M | -77.8% |
| Net Income | -$4.6M | -77.8% |
| EPS (Basic) | -$0.77 | -20.3% |
| EPS (Diluted) | -$0.77 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -35.7% |
| Accounts Receivable | $32K | -71.6% |
| Current Assets | $3.4M | -40.9% |
| Total Assets | $3.6M | -39.9% |
| Current Liabilities | $385K | -67.3% |
| Total Liabilities | $433K | -66.0% |
| Stockholders' Equity | $3.1M | -32.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -72.0% |
| Capital Expenditures | $14K | — |
| Investing Cash Flow | -$14K | -104.8% |
| Financing Cash Flow | $1.3M | -74.5% |
| Free Cash Flow | -$3.2M | — |
| -20.3% |